Zhao YY - Search Results

1

Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.

Wu XQ, Zhao L, Zhao YL, He XY, Zou L, Zhao YY, Li X. Wu XQ, et al. Among authors: zhao yl, zhao l, zhao yy. Pharm Biol. 2024 Dec;62(1):423-435. doi: 10.1080/13880209.2024.2351946. Epub 2024 May 17. Pharm Biol. 2024. PMID: 38757785 Free PMC article. Review.

2

Renal metabolic profiling of early renal injury and renoprotective effects of Poria cocos epidermis using UPLC Q-TOF/HSMS/MSE.

Zhao YY, Lei P, Chen DQ, Feng YL, Bai X. Zhao YY, et al. J Pharm Biomed Anal. 2013 Jul-Aug;81-82:202-9. doi: 10.1016/j.jpba.2013.03.028. Epub 2013 Apr 16. J Pharm Biomed Anal. 2013. PMID: 23670099

3

Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine.

Wang M, Chen L, Liu D, Chen H, Tang DD, Zhao YY. Wang M, et al. Among authors: zhao yy. Chem Biol Interact. 2017 Aug 1;273:133-141. doi: 10.1016/j.cbi.2017.06.011. Epub 2017 Jun 13. Chem Biol Interact. 2017. PMID: 28619388 Review.

4

Natural products for the prevention and treatment of kidney disease.

Chen DQ, Hu HH, Wang YN, Feng YL, Cao G, Zhao YY. Chen DQ, et al. Among authors: zhao yy. Phytomedicine. 2018 Nov 15;50:50-60. doi: 10.1016/j.phymed.2018.09.182. Epub 2018 Sep 17. Phytomedicine. 2018. PMID: 30466992 Review.

5

Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.

Feng YL, Cao G, Chen DQ, Vaziri ND, Chen L, Zhang J, Wang M, Guo Y, Zhao YY. Feng YL, et al. Among authors: zhao yy. Cell Mol Life Sci. 2019 Dec;76(24):4961-4978. doi: 10.1007/s00018-019-03155-9. Epub 2019 May 30. Cell Mol Life Sci. 2019. PMID: 31147751 Free PMC article.

6

Identification of endogenous 1-aminopyrene as a novel mediator of progressive chronic kidney disease via aryl hydrocarbon receptor activation.

Miao H, Cao G, Wu XQ, Chen YY, Chen DQ, Chen L, Vaziri ND, Feng YL, Su W, Gao Y, Zhuang S, Yu XY, Zhang L, Guo Y, Zhao YY. Miao H, et al. Among authors: zhao yy. Br J Pharmacol. 2020 Aug;177(15):3415-3435. doi: 10.1111/bph.15062. Epub 2020 May 28. Br J Pharmacol. 2020. PMID: 32219844 Free PMC article.

7

Wnt signaling pathway in aging-related tissue fibrosis and therapies.

Hu HH, Cao G, Wu XQ, Vaziri ND, Zhao YY. Hu HH, et al. Among authors: zhao yy. Ageing Res Rev. 2020 Jul;60:101063. doi: 10.1016/j.arr.2020.101063. Epub 2020 Apr 6. Ageing Res Rev. 2020. PMID: 32272170 Review.

8

Novel poricoic acids attenuate renal fibrosis through regulating redox signalling and aryl hydrocarbon receptor activation.

Wang M, Hu HH, Chen YY, Chen L, Wu XQ, Zhao YY. Wang M, et al. Among authors: zhao yy. Phytomedicine. 2020 Dec;79:153323. doi: 10.1016/j.phymed.2020.153323. Epub 2020 Sep 1. Phytomedicine. 2020. PMID: 32920287

9

Poricoic acid A as a modulator of TPH-1 expression inhibits renal fibrosis via modulating protein stability of β-catenin and β-catenin-mediated transcription.

Chen DQ, Wu XQ, Chen L, Hu HH, Wang YN, Zhao YY. Chen DQ, et al. Among authors: zhao yy. Ther Adv Chronic Dis. 2020 Sep 30;11:2040622320962648. doi: 10.1177/2040622320962648. eCollection 2020. Ther Adv Chronic Dis. 2020. PMID: 33062239 Free PMC article.

10

Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues.

Miao H, Wu XQ, Zhang DD, Wang YN, Guo Y, Li P, Xiong Q, Zhao YY. Miao H, et al. Among authors: zhao yy. Pharmacol Res. 2021 Jan;163:105316. doi: 10.1016/j.phrs.2020.105316. Epub 2020 Nov 25. Pharmacol Res. 2021. PMID: 33248198 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,381 results

Search Page

Filters